Literature DB >> 30638057

Exendin-4 prevented pancreatic beta cells from apoptosis in (Type I) diabetic mouse via keap1-Nrf2 signaling.

Jinshui He1, Xu Zhang1, Chaowei Lian1, Jinzhi Wu2, Yanling Fang1, Xiaoling Ye1.   

Abstract

IMPACT STATEMENT: Nrf2 is an essential part of the defense mechanism of vertebrates and protects them from surrounding stress via participation in stimulated expression of detoxification as well as antioxidant enzymes. It also exerts a role in defending hosts from different stress in the environment, including reactive oxygen species. Our study investigates the role of exendin-4 on Nrf2 pathway as well as cell death in pancreatic β-cell and in non-obese diabetic mice. Result of study indicates exendin-4 mediates activation of Keap1-Nrf2-ARE pathway and may serve as a potential agent to treat type I diabetes mellitus. In our research, we observed excessive reactive oxygen species production, low level of cell death, and PKC phosphorylation on exendine-4 treatment. Nrf2 knockdown led to suppression of reactive oxygen species generation as well as increasing apoptosis. Moreover, siRNA-mediated Nrf2 down-regulation attenuated the suppressive effect of exendin-4 in pancreatic β-cell viability, via modulating apoptosis promoting- and counteracting-proteins, Bax, and Bcl-2.

Entities:  

Keywords:  IDM; Keap1-Nrf2-ARE; PKC; ROS; apoptosis; exendin-4

Mesh:

Substances:

Year:  2019        PMID: 30638057      PMCID: PMC6362529          DOI: 10.1177/1535370218823549

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  35 in total

1.  Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages.

Authors:  T Ishii; K Itoh; S Takahashi; H Sato; T Yanagawa; Y Katoh; S Bannai; M Yamamoto
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

2.  Role of NRF2 in protection against hyperoxic lung injury in mice.

Authors:  Hye-Youn Cho; Anne E Jedlicka; Sekhar P M Reddy; Thomas W Kensler; Masayuki Yamamoto; Liu-Yi Zhang; Steven R Kleeberger
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

3.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.

Authors:  M Ramos-Gomez; M K Kwak; P M Dolan; K Itoh; M Yamamoto; P Talalay; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.

Authors:  A Enomoto; K Itoh; E Nagayoshi; J Haruta; T Kimura; T O'Connor; T Harada; M Yamamoto
Journal:  Toxicol Sci       Date:  2001-01       Impact factor: 4.849

Review 5.  The CD95 type I/type II model.

Authors:  Bryan C Barnhart; Elizabeth C Alappat; Marcus E Peter
Journal:  Semin Immunol       Date:  2003-06       Impact factor: 11.130

6.  Redox status and immune function in type I diabetes families.

Authors:  E Matteucci; G Malvaldi; F Fagnani; I Evangelista; O Giampietro
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 7.  Regulation and measurement of oxidative stress in apoptosis.

Authors:  James F Curtin; Maryanne Donovan; Thomas G Cotter
Journal:  J Immunol Methods       Date:  2002-07-01       Impact factor: 2.303

8.  Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner.

Authors:  Yingmei Liu; Wang Min
Journal:  Circ Res       Date:  2002-06-28       Impact factor: 17.367

9.  Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription.

Authors:  H-C Huang; Truyen Nguyen; Cecil B Pickett
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

Review 10.  Oxidation in rheumatoid arthritis.

Authors:  Carol A Hitchon; Hani S El-Gabalawy
Journal:  Arthritis Res Ther       Date:  2004-10-13       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.